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demonstrated by studies of the burden to iron-overloaded
patients receiving infused-ICT. Administration of infused-ICT
was time-consuming, inconvenient, negatively impacted patients’
HRQoL, and up to 50% of UK patients had suboptimal treat-
ment adherence, compromising morbidity and mortality. PROs
in phase II/III clinical trials comparing the efﬁcacy and safety of
deferasirox with infused-ICT revealed that at each timepoint
signiﬁcantly more patients were ‘satisﬁed or very satisﬁed’ with
deferasirox or found it to be ‘convenient or very convenient’
compared to previously received infused-ICT. Fewer hours were
lost from daily activities, 77% preferred deferasirox, and more
patients were willing to continue taking deferasirox than infused-
ICT (84% vs. 11%). The French Transparency Commission
acknowledged moderate improvement in medical beneﬁt for
deferasirox versus infused ICT considering improved HRQoL
and adherence to ICT. Use of deferasirox is recommended.
CONCLUSIONS: PROs can increase key stakeholders’ aware-
ness addressing concerns such as the medical importance of
disease and unmet needs, the therapeutic value of products, and
the beneﬁts over existing treatments from the patient perspective.
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OBJECTIVES: Quality-adjusted life-years (QALYs) measure the
number of years of perfect health provided by a health care
intervention, and are a useful measure because they combine
mortality and morbidity in one scale. QALYS are considered the
“gold-standard” for assessing the effectiveness, and thus cost-
effectiveness, of new interventions and are requested by most
reimbursement agencies, such as the UK NICE. Utility data (gen-
erally gained through quality-of-life instruments) are required to
calculate QALYs, however such data may not be available for
some drug indications. As a result, these drug indications are not
suitable for assessment via QALYs.We sought to clarify the extent
to which this is a problem. METHODS: We reviewed all prescrip-
tion drugs (including new preparations of existing drugs)
approved by the UK regulatory agency, the MHRA. Using an
online database of utility scores from Tufts University, we con-
ducted various descriptive analyses. Our primary analysis was to
establish the percentage of licensed drugs for which utility scores
are available and thus for which QALYs are a possible effective-
ness measure. RESULTS: Interim analysis of 93 licensed prepara-
tions showed that 73% had utility data available. This leaves a
substantial proportion of drugs for which QALYs may be difﬁcult
or impossible to obtain. Where QALYs are difﬁcult to obtain, this
may limit the conﬁdence with which they can be interpreted. In
other cases, QALYs may be irrelevant: these include important
indications such as anaesthesia and contraception. CONCLU-
SIONS: It is important for reimbursement agencies to recognise
that QALYs are not a universal measure, and that ﬂexibility is
required for indications in which QALYs cannot be used. An
over-emphasis on QALYs may lead to a bias against positive
recommendations in disease areas where QALYS cannot be used.
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OBJECTIVES: Inﬂuential health psychology models consider the
social context of health beliefs and their inﬂuence on medication
uptake and adherence. We conducted a systematic literature
review to identify how widely three social cognition models have
been used in transplantation and whether consideration of such
psychological factors can improve adherence to immunosuppres-
sion therapy and, consequently, the success of the transplanta-
tion. METHODS: Systematic searches were undertaken in
SCOPUS. Three social cognition models (Health Belief Model
(HBM), Theory of Reasoned Action (TRA), and Social Learning
Theory (SLT)) were paired with the search terms “transplant*”
and “immunosuppress*” in a fully inclusive search (since 1966).
RESULTS: The HBM has been used only once in transplant
research, related to adherence with immunosuppression regimens
in kidney transplant (N = 110). The study concluded that inter-
ventional strategies to increase adherence will need to consider
the variables of the HBM in order to maximise success. The TRA
has been used only twice in transplantation, on both occasions in
the general population to elicit views on organ donation. One
study (N = 298) examined reluctance to discuss organ donation
with family members. Intentions, attitudes, subjective norms,
death anxiety, and knowledge were important when reducing
communication barriers. The aim of the second study was to
investigate knowledge, behaviour and normative beliefs of stu-
dents concerning transplant and organ donations, based on the
TRA (N = 94). SLT has not been explored in transplantation but
is highlighted as a valid method for providing professional
support to live kidney donors before and after surgery. CON-
CLUSIONS: Social cognition models include a variety of psycho-
logical factors that can aid our understanding of medication
adherence. However, they have not been used widely in trans-
plant populations. Use of such models can encourage discussion
about sensitive issues surrounding organ donation and is likely to
maximise adherence to immunosuppression medication for those
undergoing transplantation.
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OBJECTIVES: This study was conducted in April 2007 at the
Taipei Medical University Hospital, which is a district teaching
hospital in Taiwan. The purpose of this study is to identify the
most important determinants of the Patient satisfaction in the
inpatient and outpatient settings. METHODS: Patient satisfac-
tion was measured in a self written survey of inpatient and
outpatient setting with the structured questionnaire including
demography, environment, service manner, administration efﬁ-
ciency, process of diagnosis and treatment. This study collected
data of 201 outpatient and 186 inpatient and were analysed with
SPSS package. Stepwise regression analysis were conducted to
help identify which factors were the most important in determin-
ing and chosen to make the best predicting model for patient
satisfaction. RESULTS: Patients were generally satisﬁed with the
mean score 4.12 and 3.77 in inpatient and outpatient respectively
(scale 1 to 5, 5 being most satisﬁed). Through the stepwise
regression analysis, in inpatient setting, the best ﬁt for patient
satisfaction standardized predicting model is : Patient Satisfac-
tion(Y) = 0.997 disease relieved (R2 = 0.954, F = 352.23.
P < 0.001); In outpatient setting, the best ﬁt for patient satis-
faction standardized predicting model is: Patient Satisfac-
tion(Y) = 0.255 hear patient reporting their condition with
patient +0.249 manner of examination services +0.194 symp-
toms relieved +0.179 the air and the light of the hospital +0.169
waiting time for the diagnosis test report (R2 = 0.666, F = 33.90,
P < 0.001). CONCLUSIONS: The results reveal that the patient
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satisfaction of inpatient and outpatient setting are inﬂuenced by
the different variables. The disease cure is enough to interpreter
the whole satisfaction in inpatient. But in outpatient setting,
other than the variable of symptoms relieved, there are more
variables inﬂuenced the patient satisfaction. However, the other
medical process such as waiting time for several stages, patient
privacy, patient right, informed consent and so on did not inﬂu-
ence patient satisfaction.
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OBJECTIVES: The PROLabels database (www.mapi-prolabels.
org) was developed to provide easy access to Patient-Reported
Outcomes (PROs) included in approved labeling of products in
Europe and the USA. Two years after its launch, the coverage of
FDA labels has been extended to give a more comprehensive
image of the current use of PROs in clinical studies. METHODS:
In 2006, the database opened with drugs approved in Europe
through the centralized procedure established by the EMEA in
January 1995 and with New Molecular Entities (NME)
approved in the USA since January 1998. The extension project
focused on other chemical types approved by FDA (e.g. New
dosage form, New combination, etc.) and on NME approved
before 1998. Once a PRO claim was identiﬁed in a label, the drug
was added in PROLabels and the following information was
retrieved: the PRO claim, description of clinical studies support-
ing the claim, description of PRO endpoints and measures used,
pharmacological action of products and information source.
RESULTS: Updated ﬁgures resulting from this major extension
of PROLabels will be presented. These new ﬁgures will include
the number of drug products present in the database with the
FDA/EMEA distribution, the most represented therapeutic areas
(currently nervous system diseases: 27.8%, immune system dis-
eases: 20.6%, respiratory tract diseases: 16.5%, pathological
conditions, signs and symptoms: 14.9%, and mental disorders:
14.6%), and the most frequently measured PROs (currently
Signs and Symptoms followed by Health-Related Quality of Life
(HRQL)). Finally, any change in the rate of PRO data found
overall in FDA approvals will be checked. CONCLUSIONS:
This extension of the FDA coverage of the PROLabels database
allows a clearer picture of the use of PROs to assess patients’
treatment beneﬁt to be drawn. In addition, it facilitates the
examination of the discrepancies between the US and European
regulatory agencies.
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OBJECTIVES: Health locus of control (HLC) is associated with
health-related behaviors such as adherence and participation in
health screening. However, HLC among physicians may be dif-
ferent from that among the general public. It is important to
understand the potential gap in HLC between physicians and the
general public. The aim of the study included two steps: 1) to
evaluate item bias of the HLC scale between physicians and the
general public, and 2) to characterize HLC among physicians
compared to the general public. METHODS: Data for the
general public were obtained from the health diary study that
involved a random sample from a nationally representative
group of households in Japan. Physicians’ data were collected
from a web-based survey of Japanese physicians. Multi-group
structural equation modeling was used for examining item bias in
the Japanese version of the HLC scale (HLCS-J) between the two
groups. Differential item functioning (DIF), including uniform
and non-uniform types, were used for measuring item bias.
Dimensions with no uniform and non-uniform DIFs were then
compared using multiple linear regressions. RESULTS: Data on
the HLCS-J of 2194 people from the general public and 895
physicians were available. Uniform DIF was recognized for the
dimensions of internal, professional control and control by spiri-
tual powers. Chance and family control dimensions had no DIF.
Mean score for chance control (17.2) among physicians was
greater than that (14.9) among the general public (adjusted
p < 0.001), while mean score for family control (21.7) among
physicians was lower than that (22.1) among the general public
(adjusted p < 0.001). CONCLUSIONS: Our psychometric evalu-
ation of the HLCS-J indicates item bias in the dimensions of
internal, professional control and control by spiritual powers.
Physicians believe that chance has a greater impact but family
control has a lesser impact on health than do members of the
general public.
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OBJECTIVES: The VAS is a common response scale in PRO
questionnaires, which are used in multinational studies from
which data is pooled. This study was designed to evaluate the
suitability of VAS for use in different international settings,
speciﬁcally to evaluate the cognitive processes and challenges
occurring when respondents from a range of countries/cultures
complete VAS. METHODS: Adults were recruited from: UK;
Mexico; Spain; Malaysia; India; South Africa, with approxi-
mately 50:50 males/females and higher/lower education split.
Each completed four VAS followed by a cognitive debrieﬁng
interview, once before and once after receiving standardized
instructions. RESULTS: Thirty-seven lay persons were inter-
viewed across 6 countries, mean age was 46  19; 51.4% were
male. Several respondents commented on the unfamiliar style of
the VAS. Some reported the anchors as inappropriate/ambiguous,
impeding scale completion, or that anchor wording caused them
to avoid scale extremities. Respondents noted the lack of inter-
mediate markers on the VAS, therefore having to rely on ‘guess-
work’: most used quantitative rather than qualitative strategies
when deciding where to place their mark. Some had concerns
that ‘guesswork’ led to inaccurate responses. British and Spanish
respondents used principally quantitative methods whereas Zulu
speakers relied more on qualitative techniques. Respondents
from Malaysia, South Africa and India were more inclined to
report challenges; Zulu and Tamil speakers completed the VAS in
the least conventional way. CONCLUSIONS: The study provides
substantial evidence that the use of VAS in different international
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